| Date | Time | Source | Headline | Symbol | Company |
| 12/01/2008 | 4:05PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 12/01/2008 | 4:00PM | Business Wire | U.S FDA Grants Pralatrexate Orphan Drug Designation for the Treatment of Patients with Follicular Lymphoma | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 11/24/2008 | 4:05PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 11/24/2008 | 4:00PM | Business Wire | U.S. FDA Grants Pralatrexate Orphan Drug Designation for the Treatment of Patients with Diffuse Large B-Cell Lymphoma | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 11/10/2008 | 5:09PM | Edgar (US Regulatory) | Amended Current report filing (8-K/A) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 11/10/2008 | 9:20AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 11/10/2008 | 9:17AM | Business Wire | Four Pralatrexate (PDX) Studies to Be Presented at the 50th Annual Meeting of the American Society of Hematology | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 11/05/2008 | 5:09PM | Edgar (US Regulatory) | Quarterly Report (10-Q) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 11/05/2008 | 4:05PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 11/05/2008 | 4:00PM | Business Wire | Allos Therapeutics Reports 2008 Third Quarter Results | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 11/04/2008 | 8:00AM | Business Wire | Allos Therapeutics to Present at the Rodman & Renshaw 10th Annual Healthcare Conference | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 10/30/2008 | 5:06PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 10/30/2008 | 5:06PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 10/30/2008 | 4:00PM | Business Wire | Four Pralatrexate (PDX) Studies Accepted for Presentation at the 50th Annual Meeting of the American Society of Hematology | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 10/30/2008 | 4:00PM | Business Wire | Four Pralatrexate (PDX) Studies Accepted for Presentation at the 50th Annual Meeting of the American Society of Hematology | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 10/29/2008 | 8:00AM | Business Wire | Allos Therapeutics to Report Third Quarter 2008 Results on November 5, 2008 | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 10/01/2008 | 8:00AM | Business Wire | Allos Therapeutics to Present at the JMP Healthcare Focus Conference | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 09/25/2008 | 9:05AM | Edgar (US Regulatory) | Allos Therapeutics Inc - Confidential Treatment Order (CT ORDER) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 09/03/2008 | 5:06PM | Edgar (US Regulatory) | Allos Therapeutics Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 09/03/2008 | 5:01PM | Edgar (US Regulatory) | Allos Therapeutics Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 09/02/2008 | 8:00AM | Business Wire | Allos Therapeutics to Present at the 3rd Annual Citi Biotech Day | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 08/28/2008 | 4:00PM | Business Wire | Allos Therapeutics to Present at the NewsMakers in the Biotech Industry Conference | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 08/27/2008 | 5:09PM | Edgar (US Regulatory) | Allos Therapeutics Inc - Confidential Treatment Order (CT ORDER) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 08/27/2008 | 5:07PM | Edgar (US Regulatory) | Allos Therapeutics Inc - Confidential Treatment Order (CT ORDER) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 08/27/2008 | 5:07PM | Edgar (US Regulatory) | Allos Therapeutics Inc - Confidential Treatment Order (CT ORDER) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 08/27/2008 | 5:06PM | Edgar (US Regulatory) | Allos Therapeutics Inc - Confidential Treatment Order (CT ORDER) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 08/25/2008 | 4:17PM | Edgar (US Regulatory) | Allos Therapeutics Inc - Amended Annual Report (10-K/A) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 08/05/2008 | 5:30PM | Edgar (US Regulatory) | Allos Therapeutics Inc - Quarterly Report (10-Q) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 08/05/2008 | 4:03PM | Edgar (US Regulatory) | Allos Therapeutics Inc - Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 08/05/2008 | 4:00PM | Business Wire | Allos Therapeutics Reports 2008 Second Quarter Results | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |